Efficacy of Olmesartan on Cerebral Glucose Metabolism Vascular Inflammation and Adipose Tissue
-
- STATUS
- Not Recruiting
-
- participants needed
- 100
-
- sponsor
- Kurume University
Nobuhiro Tahara, MD, PhD
Primary Contact
Kurume University Hospital (0.6 mi away) Contact
Summary
Hypertension is a leading risk factor for morbidity and mortality worldwide. The brain is a major target of the damaging effects of hypertension. Hypertension has been recognized as the leading cause of dementia as well as the most important risk factor for stroke and vascular cognitive impairment. Although glucose is the principal cerebral energy source, impact of hypertensive treatment on cerebral glucose metabolism is poorly understood.
Details
| Treatment | Amlodipine, Olmesartan |
|---|---|
| Clinical Study Identifier | NCT02996916 |
| Sponsor | Kurume University |
| Last Modified on | 21 January 2021 |
Adding a note
Select a piece of text and start making personal notes.
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer